NEO Financing Cash Flow
Neogenomics Inc · Financing Cash Flow
NEO Financing Cash Flow
Latest reported-$11.39Mperiod ending
NEO TTM Cash from Financing ($133.70K → -$11.39M)
TTM financing cash flow
High-resolution chart · PNG
NEO financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -11,386,000 | |
| -201,575,000 | |
| -200,288,000 | |
| -200,032,000 | |
| -199,620,000 | |
| 4,779,000 | |
| 4,646,000 | |
| 5,229,000 | |
| 5,893,000 | |
| 3,991,000 | |
| 4,554,000 | |
| 5,086,000 | |
| 6,204,000 | |
| 7,151,000 | |
| 11,829,000 | |
| 12,487,000 | |
| 2,808,000 | |
| 206,407,000 | |
| 725,285,000 | |
| 731,090,000 | |
| 741,925,000 | |
| 759,915,000 | |
| 235,597,000 | |
| 224,174,000 | |
| 220,196,000 | |
| 159,600,000 | |
| 159,466,000 | |
| 167,171,000 | |
| 269,819,000 | |
| 99,691,000 | |
| 91,959,000 | |
| 85,742,000 | |
| -20,897,000 | |
| -14,548,000 | |
| -4,095,000 | |
| -17,421,000 | |
| -14,138,000 | |
| -12,445,000 | |
| -25,871,000 | |
| 49,931,000 | |
| 49,643,000 | |
| 49,083,000 | |
| 58,493,000 | |
| -2,922,000 | |
| 30,696,000 | |
| 27,786,000 | |
| 29,007,000 | |
| 30,551,000 | |
| -3,236,000 | |
| -1,170,000 | |
| 2,750,000 | |
| 1,996,000 | |
| 4,255,000 | |
| 5,206,000 | |
| 3,384,000 | |
| 2,502,000 | |
| 1,617,000 | |
| 1,815,000 | |
| 2,359,000 | |
| 2,344,000 | |
| 2,614,000 | |
| 3,777,000 | |
| 2,434,000 | |
| 2,639,097 | |
| 5,259,480 | |
| 4,608,611 | |
| 3,627,055 | |
| 4,062,979 | |
| 875,281 | |
| 1,673,867 | |
| 897,685 | |
| 936,128 | |
| 882,322 | |
| 2,537,728 | |
| 3,443,042 | |
| 3,232,513 | |
| 3,934,625 | |
| 1,449,670 | |
| 1,207,722 | |
| 1,641,336 | |
| 1,178,241 | |
| 1,277,366 | |
| 918,075 | |
| 742,860 | |
| 835,348 | |
| 913,465 | |
| 831,562 | |
| 975,228 | |
| 768,844 | |
| 661,039 | |
| 620,605 | |
| 615,655 | |
| 716,006 | |
| 751,926 | |
| 725,579 | |
| 694,696 | |
| 477,522 | |
| 246,607 | |
| 157,314 | |
| 79,716 |